ArticleJournal of managed care & specialty pharmacy2024

Cost-effectiveness of large-panel next-generation sequencing in guiding first-line treatment decisions for patients with nonsquamous advanced non-small cell lung cancer.

Ibrahim M Abbass et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.